Israel Acquisitions Corp. Announces Amendment No. 4 to Business Combination Agreement with Gadfin Ltd.

Key Points:

• Israel Acquisitions Corp. (the “Company”) filed a Form 8-K Current Report with the SEC on April 15, 2026, announcing a material event.
• The Company entered into Amendment No. 4 to its Business Combination Agreement (“BCA”) with Gadfin Ltd., an Israeli domiciled company, and Gadfin Regev Holdings Ltd.
• This is the fourth amendment to the original BCA, which was first executed on January 26, 2025, and subsequently amended on July 2, 2025, December 31, 2025, and March 13, 2026.
• The amendment document is available as Exhibit 2.5 to the filing and is incorporated by reference.

Details of the Business Combination and Amendment:

• The ongoing business combination with Gadfin Ltd. marks a significant step in Israel Acquisitions Corp.’s strategic direction, aiming to merge with a high-growth company in the drone logistics sector.
• Gadfin Ltd. is described as a pioneering company in Israel, focused on advanced drone delivery and logistics technology.
• The repeated amendments to the BCA indicate ongoing negotiations and potentially changing deal terms, which could be crucial for investors monitoring the transaction’s progress.
• The latest amendment (No. 4) was executed on April 15, 2026, suggesting that the transaction is advancing but may still be subject to further changes or closing conditions.

Potentially Price-Sensitive Information for Shareholders:

• Material Definitive Agreement: Entry into Amendment No. 4 to the BCA is considered a material event under SEC rules, which may significantly impact the Company’s future operations, share value, and investor confidence.
• Securities Trading: The Company’s units, Class A ordinary shares (par value \$0.0001 per share), and redeemable warrants are traded on OTC Markets under the symbols “ISLUF”, “ISRLF”, and “ISLWF” respectively.
• Emerging Growth Company: Israel Acquisitions Corp. has affirmed its status as an emerging growth company, which may affect its regulatory reporting and accounting standards transitions.
• Shareholder Consideration: Amendments to the BCA can alter the terms of the transaction, including valuation, structure, and timing, all of which are highly relevant for shareholders and potential investors.
• No Exchange Listing: As of the filing date, shares and warrants are not listed on a national exchange but are traded OTC.
• No Pre-Commencement Communications: The filing confirms that no pre-commencement tender or issuer tender offers are underway pursuant to Rules 14d-2(b) or 13e-4(c) under the Exchange Act, nor any soliciting material under Rule 14a-12.

Signatures:

• The report is signed by Ziv Elul for Israel Acquisitions Corp.
• Eyal Regev signed for both Gadfin Ltd. and Gadfin Regev Holdings Ltd., indicating their involvement and consent in the amendment process.

Investor Implications:

• The ongoing negotiations and amendments to the BCA could impact the valuation and prospects of Israel Acquisitions Corp. and its target, Gadfin Ltd.
• Any delay or change in the transaction terms may affect share price volatility, and investors should monitor further SEC filings for updates.
• The business combination, if completed, would likely result in a significant change in the Company’s business profile, financials, and growth trajectory.
• The Company’s status as an emerging growth company may provide certain regulatory and financial advantages, but also risks as it transitions to new accounting standards.

Other Notable Details:

• Certain exhibits and schedules to the amendment have been omitted in accordance with SEC regulations but are available upon request.
• The Company’s business address is 12600 Hill Country Blvd, Building R, Suite 275, Bee Cave, TX 78738.
• No details regarding the specific terms of Amendment No. 4 are disclosed in this summary, but the full text is available in the filing.

Disclaimer: This article is based on Israel Acquisitions Corp.’s Form 8-K filing dated April 15, 2026. The information herein is for informational purposes only and does not constitute investment advice. Investors are encouraged to review the full SEC filing and consult with professional advisors prior to making any investment decisions. The business combination remains subject to additional approvals and conditions, and future amendments or outcomes may materially affect the Company’s share price.

View Israel Acquisitions Corp Historical chart here